ons in diabetes, obesity and Novo Nordisk ® y care DKK billion #1 80% 100 Haemophilia #3 50% 60% 40% 20% alue: 18.8% value Nov 0% 2021 e market share (RHS) market position 80 60 40 20 0 FY 2016 40% 30% 20% CAGR 3 value: 3.0% 10% Market value FY 0% 2020 NN value market share (RHS) Global market position passing agent segments, Recombinant and plasma derived products; ty care market values are based on list prices in the US.
Download PDF file